Seeking Alpha

3B NEXUS's  Instablog

3B NEXUS
Send Message
Enterprise Online Video Platform & Portal - for Investors, Corporates and Market Specialists & Media. Software-as-a-Service (SaaS) video hosting and streaming solution that helps content owners ingest, transcode, store, manage, protect, publish, syndicate, track and monetize online... More
My company:
3B NEXUS
My blog:
Bulls Bears & Butterflies®
  • Corporate Webcast: WILEX AG (WL6) - Research And Development Of Smallmolecule Drugs For Autoimmune Diseases And Cancer. 0 comments
    Feb 8, 2012 3:50 PM
    WILEX AG (WL6) - Research and development of smallmolecule drugs for autoimmune diseases and cancer.

    The therapeutic agent RENCAREX® (INN: Girentuximab) is a targeted antibody for the treatment of solid tumours. The antibody Girentuximab binds to the CA IX antigen expressed on the tumour cells, thereby triggering an immune reaction called Antibody-Dependent Cellular Cytotoxicity (OTCPK:ADCC). Through this mechanism, effector cells, e.g. NK (natural killer) cells, of the immune system are activated to kill the tumour cells.

    Broadcast live, record and publish your investor, corporate and analyst videos on 3B NEXUS for our targeted distribution. 3bnexus.com

Back To 3B NEXUS's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »
Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.